NCT02547441View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

PHASE3CompletedINTERVENTIONAL

Enrollment

463

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 5, 2017

Study Completion Date

April 13, 2018

Conditions

Rosacea

Interventions

DRUG

CLS001 (Omiganan)

Topical gel

DRUG

Vehicle

Vehicle Gel

Trial Locations (41)

Unknown

Fremont

Miami

Miramar

Tampa

Arlington Heights

Carmel

Fort Gratiot

Albuquerque

New York

Stony Brook

Dallas

San Antonio

Charlottesville

Woolloongabba

Carlton

East Melbourne

Hamilton

Toronto

Brest

Nancy

Nice

Rouen

Thionville

Augsburg

Berlin

Bochum

Darmstadt

Dresden

Dülmen

Frankfurt

Ibbenbueren

Lübeck

Mahlow

Münster

Rotterdam

Hamilton

Gothenburg

Lanarkshire

Leeds

Manchester

Surrey

All Listed Sponsors

lead

Maruho Co., Ltd.

INDUSTRY

NCT02547441 - Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | Biotech Hunter | Biotech Hunter